nonalcoholic%20fatty%20liver%20disease
NONALCOHOLIC FATTY LIVER DISEASE

Nonalcoholic fatty liver disease is having excessive hepatic fat (in the form of triglycerides) accumulation not due to excessive alcohol consumption or other secondary causes.

It is considered as a hepatic manifestation of metabolic syndrome.

Progression of nonalcoholic fatty liver disease is variable.

Follow Up

  • Patient’s follow-up schedule may vary depending on local protocol, patient’s response and risk factors
  • After 6 months, evaluate weight loss, exercise, diet and lifestyle changes
  • Twice annually the following tests should be done:
    • Blood test with platelet count
    • Liver biochemical tests
    • Prothrombin time
  • Depending on risk factors present, do the following every 1-2 years:
    • Screen for cardiovascular risk
    • Liver biopsy
  • Imaging tests can only be done when indicated
  • Screen patients with NASH cirrhosis for gastroesophageal varices 
  • Screen NAFLD patients with suspected cirrhosis for hepatocellular carcinoma
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 5 days ago
Atopic dermatitis appears to impair sleep quality, but not sleep duration, in children, particularly in those with more severe diseases, according to a new study.
6 days ago
Individuals following a diet low in or free of meat are at lower risk of diabetes, and this protective association is partly attributable to having a lower body mass index when compared with regular meat eaters, according to a study.
3 days ago
Drinking coffee confers benefits for recurrence of hepatocellular carcinoma (HCC) and survival following orthotopic liver transplantation, a study has found.
6 days ago
Vitamin E supplementation does not appear to contribute to blood pressure (BP) improvement, with results of a recent systematic review and meta-analysis showing decreases only in systolic (S)BP but no favourable effect on diastolic (D)BP and mean arterial pressure (MAP).